Our facility is located together with a variety of diverse facilities capable of fulfilling investigational requirements
encompassing many areas of research: www.itqb.unl.pt, www.ibet.pt and www.igc.gulbenkian.pt

our vision

ECBio aims at developing highly effective processes to decrease the time from discovery to the commercialization of new therapeutic solutions. ECBio focuses on the development of animal cell culture processes, namely, cell line construction and selection, cell culture optimization, cell cryopreservation, toxicological testing and recombinant protein production. With the advent of cell therapies now opening new research avenues and widening the application range of human stem cells, ECBio is also investing in stem cell and human cell technologies for clinical applications.

main achievements

scientific People at ECBio have a number of published books and papers in peer reviewed scientific journals. The main areas covered by these publications include cell biology, gene therapy, cancer therapy, metabolism, cell growth control, process development and product quality analysis. business ECBio has already contributed to the development of Biotech businesses in several areas, including: Benchmarking of management, manufacturing and marketing activities of pharmaceutical companies and regulatory and manufacturing compliance assessments. Currently ECBio is working with several hospitals in the development of new protocols for new clinical applications of human stem cells. The performance of ECBio is demonstrated by the repeated business with pharmaceutical and biotech companies and institutions.